ATC code J06

ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use.[4]

ATC codes
J Antiinfectives for systemic use
J01 Antibacterials for systemic use
J02 Antimycotics for systemic use
J04 Antimycobacterials
J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins
J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use
QJ54 Antimycobacterials for intramammary use

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J06A Immune sera

J06AA Immune sera

J06AA01 Diphtheria antitoxin
J06AA02 Tetanus antitoxin
J06AA03 Snake venom antiserum
J06AA04 Botulinum antitoxin
J06AA05 Gas-gangrene sera
J06AA06 Rabies serum

J06B Immunoglobulins

J06BA Immunoglobulins, normal human

J06BA01 Immunoglobulins, normal human, for extravascular administration
J06BA02 Immunoglobulins, normal human, for intravascular administration

J06BB Specific immunoglobulins

J06BB01 Anti-D (rh) immunoglobulin
J06BB02 Tetanus immunoglobulin
J06BB03 Varicella/zoster immunoglobulin
J06BB04 Hepatitis B immunoglobulin
J06BB05 Rabies immunoglobulin
J06BB06 Rubella immunoglobulin
J06BB07 Vaccinia immunoglobulin
J06BB08 Staphylococcus immunoglobulin
J06BB09 Cytomegalovirus immunoglobulin
J06BB10 Diphtheria immunoglobulin
J06BB11 Hepatitis A immunoglobulin
J06BB12 Encephalitis, tick-borne immunoglobulin
J06BB13 Pertussis immunoglobulin
J06BB14 Morbilli immunoglobulin
J06BB15 Parotitis immunoglobulin
J06BB19 Anthrax immunoglobulin
J06BB30 Combinations

J06BC Antibacterial monoclonal antibodies

J06BC01 Nebacumab
J06BC02 Raxibacumab
J06BC03 Bezlotoxumab
J06BC04 Obiltoxaximab

J06BD Antiviral monoclonal antibodies

J06BD01 Palivizumab
J06BD02 Motavizumab
J06BD03 Tixagevimab and cilgavimab

See also

  • Immune sera and immunoglobulins for veterinary use are in the ATCvet group QI.

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code J06". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.